☆ 4.6 Article

Risk of serious COVID-19 outcomes among adults with asthma in Scotland: a national incident cohort study

LANCET RESPIRATORY MEDICINE (2022)

Related references

Note: Only part of the references are listed.

Article Multidisciplinary Sciences

Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection

Jennifer M. Dan et al.

Summary: Different components of immune memory to SARS-CoV-2 exhibit distinct kinetics, with antibodies and spike-specific memory B cells remaining relatively stable over 6 months, while CD4(+) T cells and CD8(+) T cells declining with a half-life of 3 to 5 months after infection.

SCIENCE (2021)

Add to Collection

Letter Allergy

Asthma did not increase in-hospital COVID-19-related mortality in a tertiary UK hospital

Wei Chern Gavin Fong et al.

CLINICAL AND EXPERIMENTAL ALLERGY (2021)

Add to Collection

Letter Medicine, General & Internal

BNT162b2 and ChAdOx1 nCoV-19 Vaccine Effectiveness against Death from the Delta Variant

Aziz Sheikh et al.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Add to Collection

Article Critical Care Medicine

Risk of adverse outcomes in patients with underlying respiratory conditions admitted to hospital with COVID-19 a national, multicentre prospective cohort study using the ISARIC WHO Clinical Characterisation Protocol UK

Chloe Bloom et al.

Summary: This study analyzed data from patients admitted to hospital with COVID-19 in England, Scotland, and Wales from January 17 to August 3, 2020. The findings showed that patients with asthma were more likely to receive critical care, while patients with chronic pulmonary disease were less likely. In older patients, inhaled corticosteroid use reduced mortality rates in asthma patients but not in those with chronic pulmonary disease.

LANCET RESPIRATORY MEDICINE (2021)

Add to Collection

Article Medicine, General & Internal

Interim findings from first-dose mass COVID-19 vaccination roll-out and COVID-19 hospital admissions in Scotland: a national prospective cohort study

Eleftheria Vasileiou et al.

Summary: The study in Scotland found that the first doses of the BNT162b2 mRNA and ChAdOx1 vaccines were associated with substantial reductions in the risk of COVID-19 hospital admission, with vaccine effectiveness ranging from 88% to 91% at 28-34 days post-vaccination.

LANCET (2021)

Add to Collection

Article Critical Care Medicine

Association between pre-existing respiratory disease and its treatment, and severe COVID-19: a population cohort study

Paul Aveyard et al.

Summary: The study found that patients with certain respiratory diseases had a higher risk of hospitalization and death from COVID-19, while the risk of severe COVID-19 in asthma patients was relatively small. The use of inhaled steroids may be associated with a slightly increased risk of severe COVID-19.

LANCET RESPIRATORY MEDICINE (2021)

Add to Collection

Article Public, Environmental & Occupational Health

Cohort Profile: Early Pandemic Evaluation and Enhanced Surveillance of COVID-19 (EAVE II) Database

Rachel H. Mulholland et al.

INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2021)

Add to Collection

Letter Medicine, General & Internal

SARS-CoV-2 Delta VOC in Scotland: demographics, risk of hospital admission, and vaccine effectiveness

Aziz Sheikh et al.

LANCET (2021)

Add to Collection

Article Biochemistry & Molecular Biology

First-dose ChAdOx1 and BNT162b2 COVID-19 vaccines and thrombocytopenic, thromboembolic and hemorrhagic events in Scotland

C. R. Simpson et al.

Summary: Analysis of data from the EAVE II cohort in Scotland has shown that a first dose of the ChAdOx1 nCoV-19 vaccine may be associated with increased risks of idiopathic thrombocytopenic purpura, arterial thromboembolic events, and hemorrhagic events. However, there were no positive associations found between the BNT162b2 vaccine and these adverse events.

NATURE MEDICINE (2021)

Add to Collection

Article Multidisciplinary Sciences

Factors associated with COVID-19-related death using OpenSAFELY

Elizabeth J. Williamson et al.

NATURE (2020)

Add to Collection

Article Medicine, General & Internal

Early Pandemic Evaluation and Enhanced Surveillance of COVID-19 (EAVE II): protocol for an observational study using linked Scottish national data

Colin R. Simpson et al.

BMJ OPEN (2020)

Add to Collection

Article Critical Care Medicine

Risk of COVID-19-related death among patients with chronic obstructive pulmonary disease or asthma prescribed inhaled corticosteroids: an observational cohort study using the OpenSAFELY platform

Anna Schultze et al.

LANCET RESPIRATORY MEDICINE (2020)

Add to Collection

Article Multidisciplinary Sciences

Impact of comorbid asthma on severity of coronavirus disease (COVID-19)

Sang Chul Lee et al.

SCIENTIFIC REPORTS (2020)

Add to Collection

Article Critical Care Medicine

COVID-19 hospital admissions and deaths after BNT162b2 and ChAdOx1 nCoV-19 vaccinations in 2middot57 million people in Scotland (EAVE II): a prospective cohort study

Utkarsh Agrawal et al.

LANCET RESPIRATORY MEDICINE (2020)

Add to Collection

Article Medicine, General & Internal

The epidemiology, healthcare and societal burden and costs of asthma in the UK and its member nations: analyses of standalone and linked national databases

Mome Mukherjee et al.

BMC MEDICINE (2016)

Add to Collection

Article Surgery

The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for reporting observational studies

Erik von Elm et al.

INTERNATIONAL JOURNAL OF SURGERY (2014)

Add to Collection

© Peeref 2019-2024. All rights reserved.